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The prevalence of human papillomavirus in
pediatric tonsils: a systematic review of the
literature
Monika Wojtera1, Josee Paradis1,2, Murad Husein1,2, Anthony C. Nichols1,2, John W. Barrett1,2,
Marina I. Salvadori1,3 and Julie E. Strychowsky1,2*
Abstract
Background: HPV-related head and neck cancer rates have been increasing in recent years, with the tonsils being
the most commonly affected site. However, the current rate of HPV infection in the pediatric population remains
poorly defined. The objective of this study was to systematically review and evaluate the prevalence and distribution
of HPV in the tonsils of pediatric patients undergoing routine tonsillectomy.
Methods and Results: The literature was searched using PubMed, EMBASE, Scopus, CINAHL, Cochrane Library, and
ProQuest Dissertations & Theses Global databases (inception to December 2017) by two independent review authors.
Inclusion criteria included articles which evaluated the prevalence of HPV in a pediatric cohort without known warts or
recurrent respiratory papillomatosis, those which used tonsil biopsy specimens for analysis, and those with six or more
subjects and clear outcomes reported. Eleven studies met the inclusion criteria. Using the Oxford Clinical Evidence-
based Medicine (OCEBM) guidelines, two reviewers appraised the level of evidence of each study, extracted data, and
resolved discrepancies by consensus. The systematic review identified 11 articles (n = 2520). Seven studies detected
HPV in the subject population, with prevalence values ranging from 0 to 21%. The level of evidence for all included
studies was OCEBM Level 3.
Conclusions: HPV may be present in pediatric tonsillectomy specimens; however, the largest included study
demonstrated a prevalence of 0%. Future testing should be performed using methods with high sensitivities
and specificities, such as reverse transcript real-time PCR or digital droplet PCR.
Keywords: Pediatric, Human papillomavirus, HPV, Tonsils
Background
Human papillomavirus (HPV) is a DNA virus capable of in-
fecting skin or stratified epithelial cells. There are over 100
different types of HPV, of which at least 13 are cancer-
causing types deemed ‘high-risk’; the most common of
these being HPV 16 and 18. The remaining ‘low-risk’ types
cause non-cancerous lesions and diseases, with HPV 6 and
11 infections occurring most frequently. While sexual
transmission is the primary method of HPV infection,
vertical transmission, auto-inoculation, and other forms of
horizontal transmission have also been considered.
While most HPV infections remain subclinical and are
eventually eliminated by the immune system, some cases
may persist [1]. In children, this persistence commonly
presents as recurrent respiratory papillomatosis (RRP),
associated with HPV 6 or 11, or anogenital warts, associ-
ated with multiple HPV subtypes. In adults, presenta-
tions range from benign skin and anogenital warts due
to low-risk subtypes to more serious cervical, anal, and
head and neck cancers secondary to high-risk subtypes.
The vast majority HPV-related head and neck cancer
arises in the oropharynx, with the tonsils being the most
commonly affected site [2–4]. Despite the decreasing
frequency of tobacco- and alcohol-related oropharyngeal
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squamous cell cancer (OPSCC), the prevalence of HPV-
positive cases has been progressively increasing and is
now over 70%, due to rising rates of oral infection with
HPV [5–9]. Of note, HPV 16 accounts for the majority
of cases (> 90%) [10]. Since 6.9% of the adult population
has been found to have detectable HPV at any given
point in time [5], it is important to delineate both when
tonsillar HPV infection is first acquired and how long it
remains latent by evaluating its prevalence in the
pediatric population. However, the rate of HPV infection
in the tonsillar tissue of the pediatric population remains
poorly defined. In this manuscript, we endeavor to carry
out a systematic review of the prevalence of HPV in
pediatric patients undergoing routine tonsillectomy.
Methods
This review was conducted in accordance with the Pre-
ferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) 2009 guidelines [11].
Literature search strategy
A comprehensive literature search was performed using
PubMed, EMBASE, Scopus, CINAHL, Cochrane Library,
and ProQuest Dissertations & Theses Global databases
on December 10, 2017. Similar search strategies were
applied to search each database. The electronic database
search combined disease-specific terms (human papillo-
mavirus, HPV) with anatomic-specific terms (tonsil,
throat, pharynx, adenoid, palatine, tubal, lingual) and
pediatric-specific terms (pediatric, paediatric, children,
kid, youth, teen, preteen, minor, juvenile, virgin, pre-
pubescent, prepubescent, boy, girl, toddler, baby, babies,
infant, neonate, newborn). Initially, to ensure the consid-
eration of all relevant published articles in the initial
search, the search was not limited in terms of publica-
tion date, study design, or language of publication. Rele-
vant articles and abstracts were selected and reviewed,
and their reference lists were further searched for add-
itional publications. Next, all studies with abstracts or
full articles written in the English language were consid-
ered for inclusion.
Study selection criteria
Articles were assessed for eligibility and included if they
reported a prevalence of HPV in pediatric tonsils (age <
18 years old), regardless of study design or publication
date. Articles were excluded if they did not report results
separately for the pediatric population, if they analyzed
specimens from anatomic sites other than the palatine
tonsils, or if non-biopsy methods of tonsillar testing
were used. Where studies analyzed tonsil specimens
from adults as well as children, only the pediatric data
was used in our analysis. If discerning between the two
was not possible, the study was excluded.
To detect tonsillar HPV, studies that utilized tonsillec-
tomy specimens as a sampling method were used. The
detection of HPV using swabs of the oral mucosa, tonsil-
lar mucosa, and nasopharynx is inconsistent with the re-
sults attained by biopsy, and therefore these sampling
methods were excluded. It is theorized that HPV tends
to localize to the epithelium of tonsillar crypts, which
would account for the unreliability of tonsillar swabs as
a method of detection [12]. In cases where oropharyn-
geal scrapings were used as opposed to tonsillar scraping
or biopsy, that study or portion of the study was
excluded [13].
Articles in a foreign language were included as long as
an abstract was available in the English language and if
the abstract described the method of specimen acquisi-
tion and reported the prevalence of HPV [13, 14].
Data analysis
The methodological quality of identified studies was ap-
praised using the Oxford Center for Evidence-Based
Medicine (OCEBM) 2011 Levels of Evidence [15] and
the Newcastle-Ottawa Scale modified for cross-sectional
studies [16]. Relevant data was extracted from included
studies following tables developed a priori by two inde-
pendent review authors (M.W. and J.S.). Disagreement
was resolved by consensus. Data collected included the
country of study, number of patients, age range, mean
age, reported prevalence of HPV, testing method, types
of HPV tested, and types of HPV detected. Qualitative
and quantitative synthesis of results was performed
when applicable. A pooled proportion of the prevalence
of HPV in pediatric tonsils was considered.
Results
Six hundred twenty-six studies were identified during
the initial literature search (Fig. 1). Four hundred
seventy-nine studies remained for consideration after
duplicate publications were removed. The titles and ab-
stracts of these studies were screened for the inclusion
and exclusion criteria, and 433 studies were eliminated
because of excluded records. The remaining 46 full-text
articles were reviewed in their entirety. Eleven studies
with a total of 2520 patients met the inclusion criteria
and were included in the analysis. Among these, nine
were full-text articles in English while two were abstracts
in English with the full-text articles in another language.
Study and patient characteristics are reported in
Table 1. The number of patients enrolled in each study
ranged from 8 to 1670. HPV was detected in seven stud-
ies, and the prevalence of HPV ranged from 0 to 21%.
The geographic distribution is illustrated in Fig. 2. The
HPV subtypes that were detected varied: subtype 6 (two
studies) [14, 17], 11 (three studies) [14, 17, 18], 16 (four
studies) [17, 19–21], and 31 (one study) [17]. There was
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variability in testing methods and HPV subtypes tested,
with the majority of studies using conventional PCR with
broad-spectrum probes (8/11 studies, 72%), with four stud-
ies following up this initial screen with type-specific probes.
Three studies used real-time PCR (qPCR), and none used
reverse-transcriptase qPCR (RT-qPCR). Reporting and sub-
group analysis of the ages and genders of HPV-positive
samples was considered, but was not possible as most in-
cluded studies did not provide these details.
The OCEBM level of evidence for all 11 included stud-
ies was Level 3. Quality assessment according to the
Newcastle-Ottawa Scale modified for cross-sectional
studies is reported in Table 2.
Although a pooled statistical analysis was considered
for the collected data, the variability in sample size, geo-
graphic distribution, HPV testing methods, and types of
HPV tested would limit generalizability of possible
pooled analyses. Due to this heterogeneity, a pooled ana-
lysis of the data was not performed.
Discussion
To our knowledge, this is the first comprehensive ana-
lysis of the prevalence of HPV in pediatric tonsillar tis-
sue. Based on this systematic review of the literature, the
prevalence ranges from 0 to 21%.
Study limitations
The wide variability in the prevalence of HPV between
studies warrants discussion. While each of the studies
used biopsy specimens for testing, the majority used
conventional PCR and broad-spectrum GP5+/6+ or
MY09/11 primers. Conventional PCR has been noted to
exhibit poor specificity and consequently a high false
positive rate when testing for HPV, which may explain
some of the high prevalence findings reported [22].
qPCR is more accurate, with an improved ability to dis-
criminate between positive and negative samples based
the cycle threshold [23]. However, the gold standard is
RT-qPCR, which amplifies signals based on the presence
of viral transcripts and demonstrates the expression of
early viral proteins, as the significance of the presence of
HPV DNA in the absence of viral expression is unclear
[23]. A newer technique is digital droplet PCR (ddPCR),
which may prove to be a more sensitive technique for
HPV viral load quantification [24]. The unreliability of
conventional PCR and lack of controls in some studies
may explain the differences observed. Only three studies
[20, 25, 26] used qPCR for analysis, and none employed
RT-qPCR or ddPCR.
It is also of value to note that although the overall
prevalence of HPV ranged from 0 to 21%, the largest
study [27], encompassing 1670 patients, was unable to
Potentially relevant 
studies identified
(n = 626)
Records after duplicates 
removed
Titles/abstracts screened 
for inclusion criteria
(n = 479)
Full-text articles assessed 
for eligibility
(n = 46)
Records excluded
(n = 433)
Full-text articles excluded, with 
reasons
(n = 35)
- Adult population (n = 8)
- Unable to determine prevalence -
foreign language (n = 4)
- Looked at RRP (n = 2)
- Oral swabs used (n = 8)
- Other body part tested (n = 9)
- Reports with 5 or fewer cases (n = 4)
Studies included in 
quantitative and 
qualitative synthesis
(n = 11)
-Full text (n = 9)
-English abstract with 
foreign language article 
(n = 2)
Fig. 1 Flow diagram outlining search strategy
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detect the virus. In total, four studies found a 0% preva-
lence of HPV, comprising 1941 of this review’s 2520 pa-
tients. Studies with positive results were all completed
on a smaller scale; the largest patient sample from a
study with a positive result consisted of 177 patients, with
a prevalence of only 1% [14], suggesting potential sam-
pling or selection bias. It is also important to consider that
in all cases, tonsillar hypertrophy and chronic tonsillitis
were the indications for tonsillectomy. Although these
conditions are not known to be related to HPV infection,
it is possible that they may be confounders.
Geographical considerations
An alternate possibility for the variation in prevalence
of pediatric tonsillar HPV infection is that this infec-
tion has a geographical distribution, as illustrated in
Fig. 2, with the highest prevalence in Belgium. HPV-
related cervical lesions have been found to have a
geographical distribution [28, 29], supporting the no-
tion of such a pattern in tonsillar HPV. However, it
does not appear as though worldwide oropharyngeal
cancer incidence rates have a parallel distribution
(Fig. 3) [30]. Country-specific prevalence rates could
not be determined based on currently-available data. Of
note, the highest rates for both pediatric HPV prevalence
and oropharyngeal cancer incidence among the countries
identified was Belgium; however, there is no obvious pat-
tern beyond this. This lack of correlation could be simply
because there is no relationship between pediatric tonsillar
HPV infection and later adult oropharyngeal cancer;
perhaps pediatric patients are more easily able to elimi-
nate the infection, or prior HPV infection protects against
future infection. Alternately, a correlation between
childhood infection and adult cancer may exist, but be
difficult to discern at this time due to the currently limited
literature.
Table 1 Summary of included studies
First Study Author & Year of
Publicationa
Country # of
Patients
Age Range
(Years) [mean]
Prevalence
of HPVa
Testing Method Types of HPV Tested Types of
HPV Found
Cockerill, CC (2016) [25] [full text] b USA 129 1–12 [NR] 0% Biopsy + swabs + Roche
Cobas Amplicor test
qPCR & E6/E7 Gene-Probe
Aptima HPV test
16, 18, 31, 33, 35, 39,
45, 51, 52, 56, 58, 59,
66, 68
None
Palmer, E (2014) [27] [full text] United
Kingdom
1670 0–18 [NR] 0% Biopsy + GP5+/6+ primer
PCR enzyme immunoassay
+ PCR E6 gene targeting
for HPV16
20 types (unspecified),
14 high-risk and 6
low-risk
None
Xue, XC (2014) [26] [full text] China 42 3–12 [6.8] 0% Biopsy + MY09/11 primer
qPCR
6, 11, 16, 18, 26, 31,
33–35, 39, 40, 42–45,
51–59, 61, 66–73, 81–84
None
Sun, YF (2012) [abstract] [article
in Chinese] [14] [full text]
China 177 NR[NR] 1% Biopsy + PCR (unspecified) NR 6, 11
Duray, A (2011) [19] [full text] Belgium 42 0–15 [NR] 21% Biopsy + GP5+/GP6+ primer
PCR + E6/E7 type-specific
qPCR for multiple HPV
subtypes
6, 11, 16, 18, 31, 33, 35,
39, 45, 51, 52, 53, 56, 58,
59, 66, 68
16, NR
Baloglu, H (2010) [17] [full text] Turkey 165 5–21 [11.9] 7% Biopsy + MY/GP PCR +
E6/E7 type-specific PCR
6, 11, 16, 18, 31, 33, 35,
39, 42, 43, 44, 45, 51, 52,
56, 58, 59, 66, 68
6, 11, 16, 31
Soldatskiĭ, IuA (2009) [abstract]
[article in Russian] [13]
Russia 8 2–14 [6.8] 13% PCR 6, 11, 16, 18, 31, 33 NR
Mammas, IN (2006) [20] [full text] Greece 64 2–14 [7.1] 9% Biopsy + GP5+/6+ primer
PCR + type-specific PCR
for multiple HPV subtypes
11, 16, 18, 33 16, NR
Sisk, J (2006) [18] [full text] USA 50 3–12 [NR] 4% Biopsy + MY09/11 primer
PCR
NR 11
Ribeiro, KM (2006) [37] [full text] Brazil 100 2–13 [NR] 0% Biopsy + MY09/11 primer
PCR
NR None
Chen, R (2005) [21] [full text] Finland 73 1–16 [8.3] 8% Biopsy + GP5+/6+ &
MY09/11 primer PCR +
type-specific testing
NR 16
HPV human papillomavirus, NR not reported in the study or for the tonsillectomy portion
a Articles published in English unless otherwise specified
b This study only assessed high-risk HPV subtypes. This was also the only study to report that some patients had been vaccinated against HPV; 6 (4.7%) of patients
had received the vaccine
Wojtera et al. Journal of Otolaryngology - Head and Neck Surgery  (2018) 47:8 Page 4 of 8
Subtypes of Tonsillar HPV
Of the HPV subtypes identified among the patients in-
cluded in this study (n = 28), HPV 6, 11, 16, and 31 were
observed, with HPV 16 being the most prevalent
(78.6%). High-risk HPV 16 is the subtype most
frequently associated with OPSCC, with an average age
of diagnosis of 61 years old [7]. This suggests that the
subclinical HPV infection detected in childhood may be
a pre-malignant lesion with a long-term course, repre-
senting a risk factor for the development of tonsillar
cancer in adulthood. No studies reported long-term
follow-up to determine the incidence of possible malig-
nant transformation.
Whether this pediatric infection eventually progresses
to symptomatic disease or cancer, remains dormant for
the lifespan of the patient, or is eventually eliminated by
the host’s immune system, is currently unknown. An in-
teresting parallel is the pathogenesis of HPV infection in
the cervix, wherein persistent and often asymptomatic
HPV infection can lead to intraepithelial neoplasia and
the eventual accumulation of mutations, resulting in
cancerous invasion and metastasis [31]. A similar cycle
Fig. 2 Geographical distribution of HPV infection in pediatric tonsils. A darker shade of blue represents a higher prevalence (≥5%), while a lighter
tone represents a lower prevalence (< 5%). USA – 0%17, 4%23, United Kingdom – 0%18, China - 0%19, 1%14, Belgium – 21%20, Turkey – 7%21, Russia
– 13%13, Greece – 9%22, Brazil – 0%24, Finland – 8%25
Table 2 Quality assessment using a version of the Newcastle-Ottawa modified for cross-sectional studies
Author (Year) Selection
(Maximum 4 Stars)
Comparability
(Maximum 2 Stars)
Exposure
(Maximum 3 Stars)
Total
(Maximum 9 Stars)
Cockerill, CC (2016) [25] ** * * ****
Palmer, E (2014) [27] *** * ** ******
Xue, X-C (2014) [26] ** * ** *****
Sun, YF (2012) [abstract] [article in Chinese] [14] ** ** * *****
Duray, A (2011) [19] ** * * ****
Baloglu, H (2010) [17] ** * * ****
Soldatskiĭ, IuA (2009) [abstract] [article in Russian] [13] * * **
Mammas, IN (2006) [20] ** ** ** ******
Sisk, J (2006)[18] ** ** ** ******
Ribeiro, KM (2006)[37] ** * * ****
Chen, R (2005)[21] * * * ***
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may occur with tonsillar HPV infection, emphasizing the
importance of early detection of HPV.
HPV transmission and implications
The presence of HPV in the tonsils of pediatric patients
suggests that consideration must be given for a mode of
transmission other than sexual transmission. While sex-
ual transmission through early sexual activity or sexual
abuse remains a possibility [32–34], the detection of
HPV in infants and in high rates among youth in some
studies suggests that sexual exposure is unlikely to ac-
count for all cases. As such, vertical and horizontal
transmission must also be considered.
HPV vaccination
Both bivalent and quadrivalent vaccines against HPV are
currently available on the world market, and a 9-valent
vaccine has also been introduced in some areas. The bi-
valent vaccine is effective at preventing the high-risk HPV
16 and 18 subtypes, and the quadrivalent vaccine adds
protection against HPV 6 and 11. As of 2014, 58 countries
had introduced one or both versions of the HPV vaccine
into their national immunization programs for girls, and
countries such as Canada, the USA, Australia, and Austria
also currently advocate its use in boys [22, 35].
Despite the availability of a publicly-funded vaccine
against HPV infection in Canada, immunization rates
for HPV remain far below those of other vaccine-
preventable diseases [36]. This study calls into questions
the preconception that HPV is solely a sexually-
transmitted disease, and may be used to further vaccin-
ation campaigns in locations where stigma against
vaccination for a sexually transmitted infection is still a
barrier for larger-scale immunization campaigns.
Conclusion
HPV 6, 11, 16, and 31 may be present in some pediatric
tonsils, and their prevalence ranges from 0 to 21%. The lar-
gest study demonstrated a prevalence of 0%. A geographical
distribution could account for these discrepancies, but does
not appear to correlate with adult oropharyngeal cancer in-
cidence rates. Whether these infections are a pre-malignant
state, a transient infection, or a latent infection that will ul-
timately lead to malignant disease is yet to be determined.
Further adequately powered studies utilizing qPCR, the
gold-standard RT-qPCR, or the newer and more sensitive
ddPCR for detection of HPV are warranted to determine
the true prevalence of HPV in the pediatric population.
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